• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (COSTA RICA) UNK TISSUE EXPANDER; EXPANDER, SKIN, INFLATABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (COSTA RICA) UNK TISSUE EXPANDER; EXPANDER, SKIN, INFLATABLE Back to Search Results
Catalog Number UNK TISSUE EXPANDER
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Erythema (1840); Pain (1994)
Event Type  Injury  
Manufacturer Narrative
Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Device labeling: the following is a list of potential adverse events that may occur with breast implant surgery.The risks include: implant deflation/leakage, additional surgery, capsular contracture, infection, toxic shock syndrome, necrosis, hematoma, seroma, extrusion, breast pain, changes in nipple sensation, changes in breast sensation, dissatisfaction with cosmetic results (wrinkling, folding, displacement, asymmetry, palpability, visibility, ptosis, sloshing), calcific deposits, irritation/inflammation, delayed wound healing, hypertrophic scarring, breast tissue atrophy/chest wall deformity, difficulty/inability in breast feeding, and inability to adequately visualize breast lesions with mammography.In addition to these potential adverse events, there have been concerns with certain systemic diseases.Pain- as expected following any invasive surgical procedure, pain of varying intensity and duration may occur following tissue expander placement.In addition, the expansion process may cause some discomfort, but should not cause excessive pain.Pain may indicate expansion beyond tissue tolerance, which could result in ischemia and necrosis.Pain may also accompany other adverse reactions.Unexplained pain must be promptly investigated.Further expansion should be discontinued until the pain is resolved.Excessively rapid tissue expansion may compromise the vasculature of the overlying tissue.Stop filling immediately if any signs of tissue damage, wound dehiscence, abnormal skin pallor (e.G., blanching), erythema, edema, pain, or tenderness are observed.In the absence of other signs, some temporary erythema may occur as a recognized normal tissue response to expansion.
 
Event Description
Health professional reported left side chronic pain and redness, patient was admitted to the hospital, and received iv antibiotics.Device has been explanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK TISSUE EXPANDER
Type of Device
EXPANDER, SKIN, INFLATABLE
Manufacturer (Section D)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
CS 
Manufacturer (Section G)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
CS  
Manufacturer Contact
suzanne wojcik
301 w howard lane
suite 100
austin, TX 78753
7372473605
MDR Report Key7203174
MDR Text Key97651373
Report Number9617229-2018-00292
Device Sequence Number1
Product Code LCJ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K862203
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 01/18/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK TISSUE EXPANDER
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/03/2018
Initial Date FDA Received01/18/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ALLODERM, CIPRO, AND BACTRIM
Patient Outcome(s) Required Intervention;
-
-